Anthea Hardcastle
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease
Papers in
- Oncology 13
- Colorectal Cancer Treatments and Studies 9
-
- Biochemical and Molecular Research 8
- Histone Deacetylase Inhibitors Research 6
- Heat shock proteins research 6
- Protein Degradation and Inhibitors 4
- Cancer therapeutics and mechanisms 2
- Co-authors
- G. Wynne AherneWynne AherneFlorence I. RaynaudAnn L. JackmanPaul WorkmanLloyd R. KèllandMartin RowlandsDavid Cunningham
- Journals
- British Journal of Cancer (5 papers)Advances in experimental medicine and biology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Analytical Biochemistry (2 papers)Assay and Drug Development Technologies (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Anthea Hardcastle
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 104
- Oncology 410
- Cell Biology 219
- Molecular Biology 710
- Cancer Research 110
- Pathology and Forensic Medicine 119
Countries citing papers authored by Anthea Hardcastle
This map shows the geographic impact of Anthea Hardcastle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthea Hardcastle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthea Hardcastle more than expected).
Fields of papers citing papers by Anthea Hardcastle
This network shows the impact of papers produced by Anthea Hardcastle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthea Hardcastle. The network helps show where Anthea Hardcastle may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthea Hardcastle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 12 | |
| 2 | 2011 | 154 | |
| 3 | 2010 | 45 | |
| 4 | 2007 | 36 | |
| 5 | 2005 | 3 | |
| 6 | 2005 | 60 | |
| 7 | 2005 | 8 | |
| 8 | Mechanism of action of a novel series of inhibitors of the Hsp90 molecular chaperone | 2004 | 1 |
| 9 | Induction of Hsp70 and depletion of the client protein c-Raf-1 measured by ELISA following cellular exposure to the novel Hsp90 ATPase inhibitor, CCT018159 | 2003 | 2 |
| 10 | 2003 | 23 | |
| 11 | 2001 | 38 | |
| 12 | 2000 | 40 | |
| 13 | 1998 | 17 | |
| 14 | 1997 | 1 | |
| 15 | 1997 | 86 | |
| 16 | 1996 | 48 | |
| 17 | 1996 | 47 | |
| 18 | 1995 | 8 | |
| 19 | 1993 | 42 | |
| 20 | 1993 | 4 |
About Anthea Hardcastle
Anthea Hardcastle is a scholar working on Oncology, Molecular Biology, Cancer Research, Rheumatology and Geriatrics and Gerontology, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Biochemical and Molecular Research (8 papers), Histone Deacetylase Inhibitors Research (6 papers), Heat shock proteins research (6 papers), Protein Degradation and Inhibitors (4 papers), Folate and B Vitamins Research (4 papers), Virus-based gene therapy research (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Oncology (410 citations), Cell Biology (219 citations), Molecular Biology (710 citations), Cancer Research (110 citations) and Pathology and Forensic Medicine (119 citations). Anthea Hardcastle has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include G. Wynne Aherne, Wynne Aherne, Florence I. Raynaud, Ann L. Jackman, Paul Workman, Lloyd R. Kèlland, Martin Rowlands, David Cunningham, Laurence H. Pearl and Rosemary Kimbell. Their work appears in journals such as British Journal of Cancer, Advances in experimental medicine and biology, Cancer Chemotherapy and Pharmacology, Analytical Biochemistry and Assay and Drug Development Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.